P04.42 Newborn affected by maternal use of hallucinogens
Instructional Notes:
P04.42 Description: Newborn affected by maternal use of hallucinogens Exclude2:
newborn affected by other maternal medication (P04.1-)
↓
P04.4 Description: Newborn affected by maternal use of drugs of addiction ↓
P04 Description: Newborn affected by noxious substances transmitted via placenta or breast milk Exclude2:
congenital malformations (Q00-Q99)
encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
Code First:
any current condition in newborn, if applicable
Include:
nonteratogenic effects of substances transmitted via placenta
↓
P00-P04 Description: Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (P00-P04) Notes:
These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
↓
P00-P96 Description: Certain conditions originating in the perinatal period Exclude2:
congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
endocrine, nutritional and metabolic diseases (E00-E88)
injury, poisoning and certain other consequences of external causes (S00-T88)
neoplasms (C00-D49)
tetanus neonatorum (A33)
Notes:
Codes from this chapter are for use on newborn records only, never on maternal records
Include:
conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later